190939 ⎘
Molecular representation
#2Method of discovering specific functional antibodies
#3Interaction network inference from vector representation of words
#4Extract information from molecular pathway diagram
#5TFPI inhibitors and methods of use
#6Using nucleic acid size range for noninvasive cancer detection
#7DETECTION, MEASUREMENT, AND ANALYSIS OF DNA REPLICATION SIGNALS
#8METHOD OF SEQUENCE TYPING WITH IN SILICO APTAMERS FROM A NEXT GENERATION SEQUENCING PLATFORM
#9METHOD OF ANALYZING MICROBIOME
#10INHIBITORS OF PROTEIN METHYLTRANSFERASE DOT1L AND METHODS OF USE THEREOF
#11Immunotherapy methods for patients whose tumors carry a high passenger gene mutation burden
#12SYSTEMS, METHODS, AND PROCESSOR-READABLE MEDIA FOR DETECTING DISEASE CAUSAL VARIANTS
#13DETECTION OF HIGH-RESOLUTION STRUCTURAL VARIANTS USING LONG-READ GENOME SEQUENCE ANALYSIS
#14Monitoring and diagnosis for immunotherapy, and design for therapeutic agent
#15METHOD FOR ANALYZING A SEQUENCE OF TARGET REGIONS AND DETECT ANOMALIES
#16SUB-POPULATION DETECTION AND QUANTIZATION OF RECEPTOR-LIGAND STATES FOR CHARACTERIZING INTER-CELLULAR COMMUNICATION AND INTRATUMORAL HETEROGENEITY
#17Methods and systems for calculating free energy differences using an alchemical restraint potential
#18MACHINE LEARNING BASED ANTIBODY DESIGN
#19DATA COLLECTION METHOD TO BE USED FOR CLASSIFYING CANCER LIFE
#20Dock derived compound against laminin receptor (37 LR) and uses thereof
#21STRUCTURE OF PLASMEPSIN V IN COMPLEX WITH AN INHIBITOR AND USES THEREOF
#22In silico process for selecting protein formulation excipients
#23Method and system for spectral data analysis
#24BIOMARKER-DRIVEN MOLECULARLY TARGETED COMBINATION THERAPIES BASED ON KNOWLEDGE REPRESENTATION PATHWAY ANALYSIS
#25Methods for identifying inhibitors of amyloid protein aggregation
#26RIESKE-TYPE OXYGENASE/REDUCTASE TARGETED DRUGS FOR DIAGNOSTIC AND TREATMENT OF DISEASES
#27ENHANCED APPLICATIONS OF MOLECULAR LIBRARIES BASED ON STRUCTURE/FUNCTION ANALYSIS
#28METHOD AND DEVICE FOR CALCULATING BINDING FREE ENERGY, AND PROGRAM
#29Compositions and methods for inhibiting kinase activity
#30Methods of profiling mass spectral data using neural networks
#31Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
#32Cycle Closure Estimation of Relative Binding Affinities and Errors
#33METHOD AND APPARATUS FOR DESIGNING PROTEINS
#34Quantum mechanical/X-ray crystallography diagnostic for proteins
#35Methods for proteome docking to identify protein-ligand interactions
#36REPEAT PROTEIN ARCHITECTURES
#37Natural product and genetic data analysis and discovery system, method and computational platform therefor
#38Method for designing compounds and compositions useful for targeting high stoichiometric complexes to treat conditions, including treatment of viruses, bacteria, and cancers having acquired drug resistance
#39Method for verifying the primary structure of protein
#40Selective peptide antagonists
#41Genetic resistance prediction against antimicrobial drugs in microorganism using structural changes in the genome
#42RESTORABLE LOSSY COMPRESSION METHOD FOR SIMILARITY NETWORKS
#43Computer processes behind an enhanced version of aqua
#44Systems and methods for predicting misfolded protein epitopes by collective coordinate biasing
#45Detecting mutations and ploidy in chromosomal segments
#46Engineering and optimization of systems, methods, enzymes and guide scaffolds of CAS9 orthologs and variants for sequence manipulation
#47CALB Variants
#48SYSTEM AND METHOD FOR CLEANING NOISY GENETIC DATA AND DETERMINING CHROMOSOME COPY NUMBER
#49METHOD FOR BINDING SITE IDENTIFICATION BY MOLECULAR DYNAMICS SIMULATION (SILCS: SITE IDENTIFICATION BY LIGAND COMPETITIVE SATURATION)
#50PROTEIN BASED CRYPTOGRAPHY FOR INDIVIDUALIZED NETWORK ENCRYPTION SERVICES
#51Synthesizing vaccines, immunogens, and antibodies
#52Computer-assisted modeling for treatment design
#53Computational pipeline for antibody modeling and design
#54Protein structure prediction system
#55Method for designing RNA binding protein utilizing PPR motif, and use thereof
#56SYSTEMS AND METHODS FOR PROVIDING ASSISTED LOCAL ALIGNMENT
#57A METHOD FOR CD4+ T-CELL EPITOPE PREDICTION USING ANTIGEN STRUCTURE
#58Method for determining carbohydrates structure
#59Methods and systems for detecting genetic variants
#60METHODS FOR PREDICTION OF BINDING SITE STRUCTURE IN PROTEINS AND/OR IDENTIFICATION OF LIGAND POSES
#61Studying Molecular Interaction via Enhanced Molecular Dynamics Simulations
#62TRACE RECONSTRUCTION FROM NOISY POLYNUCLEOTIDE SEQUENCER READS
#63QUANTITATIVE FRET-BASED INTERACTION ASSAY
#64High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of MAR sequences
#65SYSTEMS AND METHODS FOR PREDICTING CARDIOTOXICITY OF MOLECULAR PARAMETERS OF A COMPOUND BASED ON MACHINE LEARNING ALGORITHMS
#66Single molecule identification using intensity time sequencing, line charting and run-length coding
#67Predicting drug-target interactions and uses for drug repositioning and repurposing
#68Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics
#69Method and system for determining copy number variation
#70TOLL-LIKE RECEPTOR 2 BINDING EPITOPE AND BINDING MEMBER THERETO
#71Compositions and methods for altering second messenger signaling
#72Methods of rational nicotine hapten design and uses thereof
#73Method for calculating binding free energy, calculation device, and program
#74Methods to Prepare and Employ Binding Site Models for Modulation of Phosphatase Activity and Selectivity Determination
#75Crystal structure of Autolysin E, method of producing the crystal and its use in screening methods
#76Compositions and methods for altering second messenger signaling
#77Systems and methods of fragment-centric topographical mapping (FCTM) to target protein-protein interactions
#78METHOD FOR DETERMINING THREE-DIMENSIONAL STRUCTURES OF DYNAMIC MOLECULES
#79METHOD AND SYSTEM FOR COMPARING PROTEINS IN THREE DIMENSIONS
#80METHOD FOR EXTRACTING LEAD COMPOUND, METHOD FOR SELECTING DRUG DISCOVERY TARGET, DEVICE FOR CREATING SCATTER DIAGRAM, AND DATA VISUALIZATION METHOD AND VISUALIZATION DEVICE
#81Method for identifying compound for inhibiting an activity of a histone lysine demethylase
#82Method and device for determining fraction of cell-free nucleic acids in biological sample and use thereof
#83Selective FKBP51 ligands for treatment of psychiatric disorders
#84Computer assisted antibody re-epitoping
#85Hyperstable Constrained Peptides and Their Design
#86SYSTEMS AND METHODS OF SELECTING COMPOUNDS WITH REDUCED RISK OF CARDIOTOXICITY USING CARDIAC SODIUM ION CHANNEL MODELS
#87INFLUENZA A 2009 PANDEMIC H1N1 POLYPEPTIDE FRAGMENTS COMPRISING ENDONUCLEASE ACTIVITY AND THEIR USE
#88Method and apparatus for new material discovery using machine learning on targeted physical property
#89Methods and systems for image alignment of at least one image to a model
#90POLYPEPTIDE FRAGMENTS COMPRISING ENDONUCLEASE ACTIVITY AND THEIR USE
#91Crystal structure of the large ribosomal subunit from
#92Agent for controlling cells constituting cancer microenvironment or inflammatory microenvironment
#93Crystal structure of human four-phosphate adaptor protein 2 glycolipid transfer protein like domain
#94Competitive inhibitors of invariant chain expression and/or ectopic clip binding
#95WATER-SOLUBLE MEMBRANE PROTEINS AND METHODS FOR THE PREPARATION AND USE THEREOF
#96Methods of making polypeptides with non-standard amino acids using genomically recoded organisms
#97Systems and methods for using geometry sensitivity information for guiding workflow
#98COMPUTATIONAL METHOD FOR CLASSIFYING AND PREDICTING PROTEIN SIDE CHAIN CONFORMATIONS
#99STRUCTURAL ANALYSIS OF PROTEINS BY STRUCTURAL REPRESENTATION AND COMPARISON OF PROTEINS
#100INTERACTION PARAMETERS FOR THE INPUT SET OF MOLECULAR STRUCTURES
#101METHODS AND SYSTEMS FOR IDENTIFYING LIGAND-PROTEIN BINDING SITES
#102Assimilating a soil sample into a digital nutrient model
#103MEDICAMENT DESIGN POCKET OF ORNITHINE DECARBOXYLASE AND APPLICATION OF MEDICAMENT DESIGN POCKET
#104COMPOSITIONS AND METHODS FOR MODULATING BODY WEIGHT
#105Electronic methods and systems for microorganism characterization
#106Screening methods for thyroid hormone disruptors based on co-regulator involved simulations
#107PROTEIN-PROTEIN INTERACTION INDUCING TECHNOLOGY
#108COMPOSITIONS AND METHODS OF SELECTIVELY INHIBITING IRP1 AND TREATING INFLAMMATION
#109Crystal structures of human Torsin-A and methods of determining and using the same
#110Self-assembling tripeptides
#111Quantum Mechanical/X-Ray Crystallography Diagnostic for Proteins
#112Methods for reformulating and repositioning pharmaceutical data and devices thereof
#113QUANTITATIVE METHODS FOR HETEROGENEOUS SAMPLE COMPOSITION DETERMINATION AND BIOCHEMICAL CHARACTERIZATION
#114Ligand-directed covalent modification of protein
#115THERMOSTABILIZED MUTANT-PREDICTING APPARATUS FOR MEMBRANE PROTEIN, A THERMOSTABILIZED MUTANT-PREDICTING METHOD, AND COMPUTER PROGRAM PRODUCT
#116METHODS FOR SCREENING THERAPEUTIC AGENT FOR PROTEIN CONFORMATIONAL DISEASES
#117METHODS, SYSTEMS, AND SOFTWARE FOR IDENTIFYING BIO-MOLECULES WITH INTERACTING COMPONENTS
#118Method of computational protein design
#119METHODS, SYSTEMS, AND SOFTWARE FOR IDENTIFYING BIO-MOLECULES USING MODELS OF MULTIPLICATIVE FORM
#120CALB variants
#121TFPI inhibitors and methods of use
#122Methods and systems for determination of an effective therapeutic regimen and drug discovery
#123Electronic methods and systems for microorganism characterization
#124ERROR CORRECTION FOR NUCLEOTIDE DATA STORES
#125METHODS AND SYSTEMS FOR IN SILICO DESIGN
#126Inhibitors of protein methyltransferase DOT1L and methods of use thereof
#127design of allosteric proteins
#128Affinity peptide ligand of mouse polyoma virus capsomer and designed screening method thereof
#129Method for designing RNA binding protein utilizing PPR motif, and use thereof
#130Methods and systems for 3D structure estimation
#131Antibody selection apparatus and methods
#132Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides
#133Method for mass humanization of non-human antibodies
#134Methods for determining correlated residues in a protein or other biopolymer using molecular dynamics
#135INFORMATION PROCESSING APPARATUS AND SIMULATION METHOD
#136BIOINFORMATIC PROCESSES FOR DETERMINATION OF PEPTIDE BINDING
#137Peptidomimetic compounds
#138Stable proteins and methods for designing same
#139Small molecule binding pockets in nucleic acids
#140Small molecule HSP70 inhibitors
#141Scar-less multi-part DNA assembly design automation
#142STRUCTURE-BASED MODELING AND TARGET-SELECTIVITY PREDICTION
#143MOLECULAR ACTIVE CENTER IDENTIFICATION USING TUNNELING BARRIERS AND/OR ASSOCIATED MEASUREMENTS FOR SUB-MOLECULAR QSAR
#144Methods of rational nicotine hapten design and uses thereof
#145SYSTEMS AND METHODS FOR PHYSICAL PARAMETER FITTING ON THE BASIS OF MANUAL REVIEW
#146COMBINATORIAL ANTIBODY DIAGNOSTIC
#147SELF-ASSEMBLING TWO-DIMENSIONAL PROTEIN ARRAYS
#148Methods to identify macromolecule binding and aggregation prone regions in proteins and uses therefor
#149Optimized Fc variants and methods for their generation
#150CRISPR-Cas systems, crystal structure and uses thereof
#151METHOD FOR SELECTING CANDIDATE LIGAND THAT BINDS TO CANCER CELL-SURFACE PROTEIN
#152Cas9 crystals and methods of use thereof
#153Optimized Fc variants and methods for their generation
#154DRUG DISCOVERY METHOD
#155Drug target site within GP120 of HIV
#156Methods of developing selective peptide antagonists
#157Systems and methods for applying a convolutional network to spatial data
#158Neuregulin variants and methods of screening and using thereof
#159METHOD AND DEVICE FOR PARTITIONING A MOLECULE
#160Methods for determining protein structure using a surface-selective nonlinear optical technique
#161Selective FKBP51 ligands for treatment of psychiatric disorders
#162Small Molecule Metal-Activated Protein Inhibition
#163METHODS FOR IDENTIFYING INHIBITORS OF AMYLOID PROTEIN AGGREGATION
#164Method for improving antibody stability
#165AMINO ACID SEQUENCE ANALYZING METHOD AND SYSTEM
#166Apparatuses and methods for annotated peptide mapping
#167SITE-SPECIFIC FRAGMENT IDENTIFICATION GUIDED BY SINGLE-STEP FREE ENERGY PERTURBATION CALCULATIONS
#168Systems and methods for genomic pattern analysis
#169METHOD OF USING A WATER-BASED PHARMACOPHORE
#170MULTI-SAMPLE DIFFERENTIAL VARIATION DETECTION
#171SYSTEMS AND METHODS OF IMPROVED MOLECULE SCREENING
#172MASS SPECTROMETRY-CLEAVABLE CROSS-LINKING AGENTS TO FACILITATE STRUCTURAL ANALYSIS OF PROTEINS AND PROTEIN COMPLEXES, AND METHOD OF USING SAME
#173NONPEPTIDE BK B2 RECEPTOR AGONISTS FOR HAIR GROWTH
#174IDENTIFYING MOLECULAR SYSTEMS IN PROTEIN SEQUENCE DATA
#175STING crystals and modulators
#176METHODS AND APPARATUS FOR PREDICTING PROTEIN STRUCTURE
#177INTER-CLASS MOLECULAR ASSOCIATION CONNECTIVITY MAPPING
#178Glycogen synthase kinase-3 inhibitors
#179Systems and methods for applying a convolutional network to spatial data
#180Universal fibronectin type III bottom-side binding domain libraries
#181Transcriptome-wide design of selective, bioactive small molecules targeting RNA
#182Rotavirus particles with chimeric surface proteins
#183Systems and methods for in silico evaluation of polymers
#184SECONDARY STRUCTURE DEFINING DATABASE AND METHODS FOR DETERMINING IDENTITY AND GEOGRAPHIC ORIGIN OF AN UNKNOWN BIOAGENT THEREBY
#185RATIONAL METHOD FOR SOLUBILISING PROTEINS
#186CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XIIIA
#187Computer-implemented methods of determining protein viscosity
#188Method for Characterising Three-Dimensional Objects
#189Techniques for controlling spatial structure of nucleic acid structures based on lattice-free, three dimensional junction coordinates
#190HLA typing using selective amplification and sequencing
#191Methods and devices for collection and heuristic analysis of large-scale biographical information
#192Method for binding site identification by molecular dynamics simulation (silcs: site identification by ligand competitive saturation)
#193Methods for Lung Cancer Detection
#194Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics
#195Compositions and methods for altering second messenger signaling
#196Analysis of Biomolecular Solvation Sites by the 3D-RISM Theory
#197Automated method of computational enzyme identification and design
#198Systems, Algorithms, and Software for Molecular Inversion Probe (MIP) Design
#199Influenza A 2009 pandemic H1N1 polypeptide fragments comprising endonuclease activity and their use
#200Methods and systems for detecting genetic variants
#201Systems and methods for identifying thermodynamic effects of atomic changes to polymers
#202METHOD AND DEVICE FOR DETERMINING ONE OR MORE ENZYMES FOR BIOCHEMICAL TRANSFORMATION
#203Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
#204PHARMACEUTICAL PLATFORM TECHNOLOGY FOR THE DEVELOPMENT OF NATURAL PRODUCTS
#205Water-soluble trans-membrane proteins and methods for the preparation and use thereof
#206WATER-SOLUBLE MEMBRANE PROTEINS AND METHODS FOR THE PREPARATION AND USE THEREOF
#207Method for development of a peptide building block useful for de novo protein design
#208Self-assembling protein nanostructures
#209High-throughput methodology for identifying RNA-protein interactions transcriptome-wide
#210Peptidomimetic compounds
#211METHODS OF INHIBITING PRMT5
#212METHOD OF SCREENING CANDIDATE BIOCHEMICAL ENTITIES TARGETING A TARGET BIOCHEMICAL ENTITY
#213Recombinant meso-active thermo-stable protein and processes of design and biosynthesis thereof
#214Compounds that inhibit human DNA ligases and methods of treating cancer
#215Compound Design Device, Compound Design Method, And Computer Program
#216Determining novel enzymatic functionalities using three-dimensional point clouds representing physico chemical properties of protein cavities
#217Device and methods for analysis of biomolecule structure, dynamics and activity
#218INHIBITORS OF PROTEIN METHYLTRANSFERASE DOT1L AND METHODS OF USE THEREOF
#219AUTOMATED PRODUCT CUSTOMIZATION BASED UPON LITERATURE SEARCH RESULTS
#220Systems and methods for using geometry sensitivity information for guiding workflow
#221Method and system for molecular dynamics simulation with stability control
#222Detection of gene fusions by intragenic differential expression (IDE) using average cycle thresholds
#223Method of preparing base sequence of 5′-cohesive end for synthesizing branched nucleic acid nanostructure
#224Crystal Structure of Queuosine Biosynthesis Enzyme QueF Bound to Substrate PreQ0
#225Encoding and decoding of RNA data
#226ENGINEERING SURFACE EPITOPES TO IMPROVE PROTEIN CRYSTALLIZATION
#227Method for identifying compound for inhibiting an activity of a histone lysine demethylase
#228Biosensor chip having precise count function and method of sensing amount of cells
#229CRYSTAL STRUCTURE
#230Electronic methods and systems for microorganism characterization
#231METHODS AND SYSTEMS FOR MICROFLUIDICS IMAGING AND ANALYSIS
#232Methods and tools for identification of RSK/MSK kinase inhibitors
#233METHOD AND DEVICE FOR ANALYZING MICROBIAL COMMUNITY COMPOSITION
#234LANTHIONINE SYNTHETASE COMPONENT C-LIKE PROTEINS AS MOLECULAR TARGETS FOR PREVENTING AND TREATING DISEASES AND DISORDERS
#235TFPI inhibitors and methods of use
#236COMPETITIVE INHIBITORS OF INVARIANT CHAIN EXPRESSION AND/OR ECTOPIC CLIP BINDING
#237Method for identifying compounds of therapeutic interest
#238METHODS FOR THE HUMANIZATION OF ANTIBODIES AND HUMANIZED ANTIBODIES THEREBY OBTAINED
#239Self-assembly of nucleic acid nanostructures
#240Linked purine pterin HPPK inhibitors useful as antibacterial agents
#241Methods and systems for determination of an effective therapeutic regimen and drug discovery
#242Methods to identify amino acid residues involved in macromolecular binding and uses therefor
#243SYSTEMS AND METHODS OF SELECTING COMPOUNDS WITH REDUCED RISK OF CARDIOTOXICITY
#244Bioinformatics platform for high-throughput identification and quantification of N—glycopeptide
#245METHOD AND DEVICE FOR DETERMINING HYDROPHOBIC ENERGY OF PROTEIN
#246INTERACTION PREDICTION DEVICE, INTERACTION PREDICTION METHOD, AND COMPUTER PROGRAM PRODUCT
#247Reprogramming effector protein interactions to correct epigenetic defects in cancer
#248Screening method and systems utilizing mass spectral fragmentation patterns
#249Systems and methods for identifying thermodynamically relevant polymer conformations
#250STRUCTURE BASED PREDICTIVE MODELING
#251Polypeptide fragments comprising endonuclease activity and their use
#252Methods for the Characterisation of Interaction Sites on Target Proteins
#253Crystal Structure of a NEF/SdAb19 Complex and Uses Thereof
#254Means and methods for generating improved proteins
#255METHOD FOR ANALYZING THE THREE DIMENSIONAL STRUCTURE OF A GPCR
#256SYSTEMS AND METHODS FOR MAKING TWO DIMENSIONAL GRAPHS OF COMPLEX MOLECULES
#257METHODS FOR IN SILICO SCREENING
#258CRYSTAL STRUCTURE OF A TYPE IB P-TYPE ATPase
#259Toll-like receptor 2 binding epitope and binding member thereto
#260Hybrid alpha-amylases
#261CANCER-TARGETING PEPTIDES AND USES THEREOF IN CANCER TREATMENT AND DIAGNONSIS
#262METHOD AND SYSTEM FOR IDENTIFYING COMPOUNDS THAT BIND AND/OR ACTIVATE A TARGET OPIOID RECEPTOR IN A PH-DEPENDENT MANNER
#263Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof
#264Method of Gap Closing in Nucleotide Sequence and Apparatus Thereof
#265Real-time analysis for cross-linked peptides
#266Method for designing RNA binding protein utilizing PPR motif, and use thereof
#267Cyclin based inhibitors of CDK2 and CDK4
#268ANALYSIS DEVICE AND SIMULATION METHOD
#269GPCR fusion protein containing an N-terminal autonomously folding stable domain, and crystals of the same
#270SELECTIVE GPCR LIGANDS
#271METHOD FOR DETERMINING AND PREDICTING PROTEIN AUTONOMOUS FOLDING
#272G-quadruplex binding assays and compounds therefor
#273Methods for Identifying Janus Kinase (JAK) Modulators for Therapeutics
#274Methods for shape comparison between drug molecules
#275Small molecule malarial Aldolase-TRAP enhancers and glideosome inhibitors
#276SYSTEM AND METHOD FOR ESTIMATING GLUCOSE IN PLASMA
#277Peptide linkers for effective multivalent peptide binding
#278Methods, systems, and software for identifying bio-molecules using models of multiplicative form
#279Methods, systems, and software for identifying bio-molecules with interacting components
#280ANTIBODIES WITH IMPROVED FOLDING STABILITY
#281Methods for analyzing biological macromolecular complexes and use thereof
#282Non-parametric methods for mass spectromic relative quantification and analyte differential abundance detection
#283Phenylethanolamine-based NMDA receptor antagonists
#284METHOD FOR IDENTIFYING INHIBITORS OF STAPHYLOCOCCUS AUREUS
#285Methods of targeted drug development
#286SELF-SIMILAR ORDERED MICROSTRUCTURAL ARRAYS OF AMPHIPHILIC MOLECULES
#287METHODS AND COMPOSITIONS OF TARGETED DRUG DEVELOPMENT
#288Pharmacophores for Amyloid Fibers Involved in Alzheimer's Disease
#289SYSTEM AND METHOD FOR ALIGNING GENOME SEQUENCE
#290HLA typing using selective amplification and sequencing
#291Rational design of components of the oligo-saccharyltransferase-catalysed asparagine-linked glycosylation
#292COMPUTATIONAL METHODS FOR ANALYSIS AND MOLECULAR DESIGN OF ANTIBODIES, ANTIBODY HUMANIZATION, AND EPITOPE MAPPING COUPLED TO A USER-INTERACTIVE WEB BROWSER WITH EMBEDDED THREE- DIMENSIONAL RENDERING
#293METHOD OF PREDICTING DNA 3D STRUCTURE BASED ON PRIMARY DNA SEQUENCE
#294Pharmaceutical compositions and treatment of genetic diseases associated with nonsense mediated RNA decay
#295Water-soluble polypeptides comprised of repeat modules, method for preparing the same and method for a target-specific polypeptide and analysis of biological activity thereof
#296Crystal structure
#297STRUCTURES OF HUMAN HISTIDYL-TRNA SYNTHETASE AND METHODS OF USE
#298LEARNING TO PREDICT EFFECTS OF COMPOUNDS ON TARGETS
#299PROTEIN SYNTHESIS MODULATORS
#300INTER-CLASS MOLECULAR ASSOCIATION CONNECTIVITY MAPPING